Caveolin-3 deficiency causes muscle degeneration in mice.

Caveolin-3 is a muscle-specific protein integrated in the caveolae, which are small invaginations of the plasma membrane. Mutations of the caveolin-3 gene, localized at 3p25, have been reported to be involved in the pathogenesis of limb-girdle muscular dystrophy (LGMD1C or caveolinopathy) with mild clinical symptoms, inherited through an autosomal dominant form of genetic transmission. To elucidate the pathogenetic mechanism, we developed caveolin-3-deficient mice for use as animal models of caveolinopathy. Caveolin-3 mRNA and its protein were absent in homozygous mutant mice. In heterozygous mutant mice, both the mRNA and its protein were normal in size, but their amounts were reduced by about half. The density of caveolae in skeletal muscle plasma membrane was roughly proportional to the amount of caveolin-3. In homozygous mutant mice, muscle degeneration was recognized in soleus muscle at 8 weeks of age and in the diaphragm from 8 to 30 weeks, although there was no difference in growth and movement between wild-type and mutant mice. No apparent muscle degeneration was observed in heterozygous mutant mice, indicating that pathological changes caused by caveolin-3 gene disruption were inherited through the recessive form of genetic transmission.

[1]  S. Fine,et al.  Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. Hama,et al.  Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. , 2000, Human molecular genetics.

[3]  K. Campbell,et al.  Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. , 2000, Molecular cell.

[4]  K. Campbell,et al.  Disruption of the b-Sarcoglycan Gene Reveals Pathogenetic Complexity of Limb-Girdle Muscular Dystrophy Type 2 , 2000 .

[5]  K. Pelin,et al.  Mutations in the skeletal muscle α-actin gene in patients with actin myopathy and nemaline myopathy , 1999, Nature Genetics.

[6]  M. Lisanti,et al.  Phenotypic Behavior of Caveolin-3 Mutations That Cause Autosomal Dominant Limb Girdle Muscular Dystrophy (LGMD-1C) , 1999, The Journal of Biological Chemistry.

[7]  H. Hama,et al.  Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. , 1999, Human molecular genetics.

[8]  K. Campbell,et al.  Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth Muscle A Novel Mechanism for Cardiomyopathy and Muscular Dystrophy , 1999, Cell.

[9]  John A. Faulkner,et al.  Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice , 1998, The Journal of cell biology.

[10]  R. Wollmann,et al.  γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin , 1998, The Journal of cell biology.

[11]  J. Engelman,et al.  Mutational analysis of caveolin‐induced vesicle formation , 1998, FEBS letters.

[12]  J. Engelman,et al.  Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav‐1, ‐2, and ‐3) , 1998, FEBS letters.

[13]  K. Campbell,et al.  Caveolin‐3 is not an integral component of the dystrophin glycoprotein complex , 1998, FEBS letters.

[14]  L. Kunkel,et al.  Caveolin-3 in muscular dystrophy. , 1998, Human molecular genetics.

[15]  F. Zara,et al.  Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy , 1998, Nature Genetics.

[16]  S. Noguchi,et al.  From dystrophinopathy to sarcoglycanopathy: Evolution of a concept of muscular dystrophy , 1998, Muscle & nerve.

[17]  M. Lisanti,et al.  Caveolins, a Family of Scaffolding Proteins for Organizing “Preassembled Signaling Complexes” at the Plasma Membrane* , 1998, The Journal of Biological Chemistry.

[18]  H. Ju,et al.  Interaction of Neuronal Nitric-oxide Synthase with Caveolin-3 in Skeletal Muscle , 1997, The Journal of Biological Chemistry.

[19]  K. Campbell,et al.  Animal Models for Muscular Dystrophy Show Different Patterns of Sarcolemmal Disruption , 1997, The Journal of cell biology.

[20]  S. Nagataki,et al.  Distribution of intramembranous particle size in the muscle plasma membrane of the mdx mouse , 1997, Journal of the Neurological Sciences.

[21]  M. Lisanti,et al.  Molecular and cellular biology of caveolae paradoxes and plasticities. , 1997, Trends in cardiovascular medicine.

[22]  Tsuneya Ikezu,et al.  Identification of Peptide and Protein Ligands for the Caveolin-scaffolding Domain , 1997, The Journal of Biological Chemistry.

[23]  M. Lisanti,et al.  Mutational Analysis of the Properties of Caveolin-1 , 1997, The Journal of Biological Chemistry.

[24]  R. Parton,et al.  Caveolae and caveolins. , 1996, Current opinion in cell biology.

[25]  M. Lisanti,et al.  Expression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.

[26]  H. Lodish,et al.  Molecular Cloning of Caveolin-3, a Novel Member of the Caveolin Gene Family Expressed Predominantly in Muscle (*) , 1996, The Journal of Biological Chemistry.

[27]  H. Lodish,et al.  Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Parton,et al.  M‐caveolin, a muscle‐specific caveolin‐related protein , 1995, FEBS letters.

[29]  A. Nishikawa,et al.  Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. , 1995, Journal of biochemistry.

[30]  M. Lisanti,et al.  Oligomeric structure of caveolin: implications for caveolae membrane organization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  F. Vogel,et al.  VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. , 1995, Molecular biology of the cell.

[32]  H. Yamamoto,et al.  Distribution of dystrophin isoforms and dystrophin-associated proteins 43DAG (A3a) and 50DAG (A2) in various monkey tissues. , 1993, Journal of biochemistry.

[33]  R. Bronson,et al.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.

[34]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[35]  K. Moore,et al.  X chromosome-linked muscular dystrophy (mdx) in the mouse. , 1984, Proceedings of the National Academy of Sciences of the United States of America.